Latest Breaking News On - Humanitarian device - Page 1 : comparemela.com

Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow

22.04.2024 - TORONTO, April 22, 2024 (GLOBE NEWSWIRE) - Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of .

Stephen kilmerHealth canadaChina national medical products administrationDrug administrationFirst quarterConference call detailsCall registrationHumanitarian device

Enterra® II System—an Advanced Treatment for Gastroparesis—Receives FDA Approval for MR Conditional Use

Enterra® II System—an Advanced Treatment for Gastroparesis—Receives FDA Approval for MR Conditional Use
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJenny rogersKenneth kochPeter sommernessEnterra medical incDrug administrationUnited states foodEnterra therapyMagnetic resonance imagingChief executive officerVice presidentMedical directorHumanitarian deviceGastric electrical stimulationTherapy systemEnterra medical

ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT

WESTMINSTER, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 2,000 children worldwide

New yorkUnited statesLaura driscollRebecca whitneyZimmer biometMark richardsMarissa bychGilmartin groupExchange commissionZimvie incVertebral body tetheringHumanitarian deviceBaron lonnerMinimally invasive scoliosis surgeryPediatric spineMount sinai hospital

Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13

21.09.2023 - TORONTO, Sept. 21, 2023 (GLOBE NEWSWIRE) - Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of .

Stephen kilmerChina national medical products administrationDrug administrationHealth canadaHumanitarian deviceSave the date

Profound Medical to Participate in A.G.P.'s Virtual Healthcare Conference

18.05.2023 - TORONTO, May 18, 2023 (GLOBE NEWSWIRE) - Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of .

Stephen kilmerHealth canadaDrug administrationChina national medical products administrationAbout profound medicalHumanitarian device